A prospective, multicenter, open, randomized, comparative study to evaluate the safety and efficacy of ertapenem versus it's comparator in the treatment of complicated intra-abdominal infections in adults.

Trial Profile

A prospective, multicenter, open, randomized, comparative study to evaluate the safety and efficacy of ertapenem versus it's comparator in the treatment of complicated intra-abdominal infections in adults.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Ertapenem (Primary) ; Antibacterials
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 10 Nov 2009 Actual end date (1 Sep 2004) added as reported by ClinicalTrials.gov record.
    • 10 Nov 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov
    • 03 Nov 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top